Evidence for the effectiveness of pomegranate supplementation for blood pressure management is weak: A systematic review of randomized clinical trials - PubMed (original) (raw)

Review

Evidence for the effectiveness of pomegranate supplementation for blood pressure management is weak: A systematic review of randomized clinical trials

Oghenekome A Gbinigie et al. Nutr Res. 2017 Oct.

Abstract

Hypertension is one of the most important preventable causes of premature death. Studies have been conducted assessing the impact of pomegranate on blood pressure, with varying results. The aim of this review was to critically appraise and evaluate the effect of pomegranate on blood pressure in adults, using evidence from randomized clinical trials (RCTs). We conducted electronic searches in Medline, Embase, Amed, and The Cochrane Library, and included RCTs assessing the effectiveness of pomegranate on blood pressure. We assessed the reporting quality using the Cochrane criteria. We included 8 RCTs comprising 619 participants. The studies varied in their reporting quality, and compared pomegranate juice or capsules with a control. Two studies reported significant reductions in systolic blood pressure favoring pomegranate: p = .002 and p < .001 respectively; 3 studies reported no significant differences between groups; and 3 studies failed to report between-group differences. Two studies reported significant reductions in diastolic blood pressure favoring pomegranate: p = .038, p < .001, respectively; 4 studies reported no significant between-group differences; and 2 studies did not report between group differences. No adverse events were observed. The limited evidence from clinical trials to date fails to convincingly show a beneficial effect of pomegranate on blood pressure. We have identified evidence gaps and highlight areas for future research to be conducted, including performing studies of high quality and longer duration.

Keywords: Blood pressure; Cardiovascular disease; Fruit; Pomegranate; Systematic Review.

PubMed Disclaimer

Cited by

Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway.
Singh R, Chandrashekharappa S, Bodduluri SR, Baby BV, Hegde B, Kotla NG, Hiwale AA, Saiyed T, Patel P, Vijay-Kumar M, Langille MGI, Douglas GM, Cheng X, Rouchka EC, Waigel SJ, Dryden GW, Alatassi H, Zhang HG, Haribabu B, Vemula PK, Jala VR. Singh R, et al. Nat Commun. 2019 Jan 9;10(1):89. doi: 10.1038/s41467-018-07859-7. Nat Commun. 2019. PMID: 30626868 Free PMC article.
Ellagic Acid: A Review on Its Natural Sources, Chemical Stability, and Therapeutic Potential.
Sharifi-Rad J, Quispe C, Castillo CMS, Caroca R, Lazo-Vélez MA, Antonyak H, Polishchuk A, Lysiuk R, Oliinyk P, De Masi L, Bontempo P, Martorell M, Daştan SD, Rigano D, Wink M, Cho WC. Sharifi-Rad J, et al. Oxid Med Cell Longev. 2022 Feb 21;2022:3848084. doi: 10.1155/2022/3848084. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 35237379 Free PMC article. Retracted. Review.
Ellagic Acid Suppresses ApoB Secretion and Enhances ApoA-1 Secretion from Human Hepatoma Cells, HepG2.
Ieda A, Wada M, Moriyasu Y, Okuno Y, Zaima N, Moriyama T. Ieda A, et al. Molecules. 2021 Jun 25;26(13):3885. doi: 10.3390/molecules26133885. Molecules. 2021. PMID: 34202121 Free PMC article.
Pomegranate variety and pomegranate plant part, relevance from bioactive point of view: a review.
Melgarejo-Sánchez P, Núñez-Gómez D, Martínez-Nicolás JJ, Hernández F, Legua P, Melgarejo P. Melgarejo-Sánchez P, et al. Bioresour Bioprocess. 2021 Jan 3;8(1):2. doi: 10.1186/s40643-020-00351-5. Bioresour Bioprocess. 2021. PMID: 38650225 Free PMC article. Review.
Genome-Wide Identification and Comprehensive Analysis of the AP2/ERF Gene Family in Pomegranate Fruit Development and Postharvest Preservation.
Wan R, Song J, Lv Z, Qi X, Han X, Guo Q, Wang S, Shi J, Jian Z, Hu Q, Chen Y. Wan R, et al. Genes (Basel). 2022 May 17;13(5):895. doi: 10.3390/genes13050895. Genes (Basel). 2022. PMID: 35627280 Free PMC article.

Evidence for the effectiveness of pomegranate supplementation for blood pressure management is weak: A systematic review of randomized clinical trials - PubMed (original) (raw)